Cetera Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Cetera Advisors's BMY Position: Q1 2024 in Review
Cetera Advisors sold out of Bristol-Myers Squibb (BMY) in Q1 2024, closing a stake of 121,611 shares — an estimated $6.24M sold.
Cetera Advisors first reported a position in BMY in Q2 2013 and held it in 43 quarters. The position peaked at $12.1M in Q2 2022. 2,334 funds tracked by Wall St. Rank hold BMY as of Q1 2024.
- Cetera Advisors reported no remaining Bristol-Myers Squibb position as of Q1 2024 after selling out during the quarter.
- Cetera Advisors sold 121,611 Bristol-Myers Squibb shares in Q1 2024, an estimated $6.24M.
- Cetera Advisors first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 43 quarters.
- Cetera Advisors's Bristol-Myers Squibb position peaked at $12.1M in Q2 2022.
- 2,334 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2024.
Based on Cetera Advisors's 13F filing for Q1 2024.